BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
202 hedge funds and large institutions have $952M invested in BioTelemetry, Inc. in 2018 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 80 increasing their positions, 61 reducing their positions, and 27 closing their positions.
41% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 27
31% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 61
28% more call options, than puts
Call options by funds: $10.3M | Put options by funds: $8.07M
11% more capital invested
Capital invested by funds: $856M → $952M (+$96.2M)
5% more funds holding
Funds holding: 192 → 202 (+10)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$21M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$16.6M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$15.1M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$12.8M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$16.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.91M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$7.9M |
| 4 |
CC
Cannell Capital
Alta,
Wyoming
|
-$7.47M |
| 5 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$5.01M |
BEAT Hedge Fund Activity: Q1 2018 in Review
202 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q1 2018, worth a combined $952M — up 11% from $856M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new BEAT positions and 27 closed out — a net gain of 11 holders — while 80 added to existing stakes and 61 trimmed.
The largest buyer was Credit Suisse, adding an estimated $21M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $16.8M sold.
- 202 institutional investors held BioTelemetry, Inc. (BEAT) as of Q1 2018, up from 192 in Q4 2017.
- Funds reported $952M of BioTelemetry, Inc. stock for Q1 2018, up 11% quarter-over-quarter.
- 38 funds opened new BioTelemetry, Inc. positions in Q1 2018 and 27 closed out, a net change of +11 holders.
- The largest BioTelemetry, Inc. buyer in Q1 2018 was Credit Suisse, an estimated $21M added.
- The largest BioTelemetry, Inc. seller in Q1 2018 was Renaissance Technologies, an estimated $16.8M sold.
Based on aggregated 13F filings for Q1 2018.